Metribolone
Metribolone (also known as methyltrienolone or R1881) is a potent, non-aromatizable androgen that is used in scientific research and has been sold online as a designer steroid. Metribolone is an oral steroid and is one of the strongest available on the market, it is also one of the most hepatotoxic and is not recommended for practical use.
History[edit]
Metribolone was first described in 1965. It was immediately recognized as an extraordinarily potent anabolic agent, significantly more potent than the reference anabolic steroid in that study, fluoxymesterone. However, its potential for liver toxicity was also quickly realized.
Pharmacology[edit]
As an AAS, metribolone is an agonist of the androgen receptor (AR), similarly to androgens like testosterone and dihydrotestosterone (DHT). It is one of the most potent AAS to have ever been synthesized, with 120–300 times the oral anabolic potency and 60–70 times the androgenic potency of methyltestosterone, and 12 times the oral anabolic potency and 2.5 times the androgenic potency of oxymetholone.
Side Effects[edit]
Metribolone is considered one of the most toxic steroids. It is both highly hepatotoxic and capable of causing damage to the liver. It also has potential side effects in many other areas, including cardiovascular complications, and potential direct neurological and mental changes. It is so dangerous that it is often used in research studies to induce damage to the liver as it is so reliably toxic.
Legal Status[edit]
In the United States, metribolone is classified as a Schedule III controlled substance under federal regulation, under the Controlled Substances Act. It is also banned by many sporting organizations, including the International Olympic Committee.
See Also[edit]
-
Metribolone chemical structure
-
Metribolone molecule ball model
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

